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Abstract 
Inhibitor titrations were applied to characterize functional changes in mitochondrial energy metabolism in the skeletal 
muscle of patients with mitochondrial diseases. For this we titrated the maximal mitochondrial respiration rate of 
saponin-skinned muscle fibers isolated from the skeletal muscle biopsy with the specific inhibitors of mitochondrial 
oxidative phosphorylation complexes I, IV and V-rotenone, azide and oligomycin. For three patients with deletions of 
mitochondrial DNA and one patient with a complex I deficiency the titrations revealed at rather normal respiration activities 
of saponin-skinned fibers significant differences to healthy controls: (i) The inhibitor titration curves of the affected enzyme 
were much steeper and (ii) for almost complete inhibition of respiration a smaller amount of the inhibitor is necessary. The 
detailed analysis of the titration curves within the framework of metabolic ontrol theory indicated elevated flux control 
coefficients of the respective complex of respiratory chain. On the other hand, for one patient with a mitochondrial DNA 
depletion syndrome, decreased respiration activities of skinned fibers but no redistribution of flux control was observed. We 
conclude, therefore, that application of inhibitor titrations and the quantitative description of the titration curve can be a 
valuable approach to elucidate functional defects of mitochondrial oxidative phosphorylation. 
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1. Introduction 
A rather larger number of human diseases has been 
identified which are caused by a defective mitochon- 
drial oxidative phosphorylation [1-3]. These defects 
* Corresponding author. Fax: + 49 391 6715228. 
are detected on the basis of functional abnormalities 
of mitochondria that are in the majority of described 
cases the result of mutations of the mitochondrial 
DNA [1]. The functional abnormalities of oxidative 
phosphorylation are usually visible as decreased ac- 
tivities of mitochondrial enzymes in the affected tis- 
sues. In some cases decreased maximal rates of mito- 
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chondrial respiration are also reported [3-5]. How- 
ever, due to the problems of the exact determination 
of activities of the individual complexes of respira- 
tory chain in human muscle homogenates and due to 
the possible adaptational changes in muscle energy 
metabolism in response to these defects, the exact 
detection of the impairment in mitochondrial function 
is often rather problematic. This seems to be an 
explanation for reported discrepancies between de- 
tected mitochondrial DNA mutations and almost nor- 
mal activities of mtDNA-encoded enzymes in muscle 
homogenates from patients with chronic progressive 
external ophthalmoplegia [6]. 
Metabolic control analysis [7,8] has been sug- 
gested to be useful for the description of enzymatic 
abnormalities in syndromes associated with mito- 
chondrial dysfunction [9,10]. This theory describes 
quantitatively the metabolic effect of a small change 
in an enzyme concentration. In diseases affecting 
oxidative phosphorylation such a small change oc- 
curs, whereas rather large fluctuations of enzyme 
activities, reported in defects of other metabolic path- 
ways [11], are for obvious reasons lethal. Applying 
metabolic ontrol analysis, we recently reported ele- 
vated flux control coefficients of cytochrome c oxi- 
dase in Mo br mice, an animal model of the Menkes' 
syndrome with established cytochrome c oxidase de- 
ficiency in cardiac and skeletal muscles [12]. Contin- 
uing this study, we used metabolic ontrol theory to 
elucidate the consequences of impairment of mito- 
chondrial function in patients with mitochondrial dis- 
eases. We performed incremental inhibition of the 
mitochondrial respiration with the specific inhibitors 
of NADH:ubiquinone reductase (complex I), cyto- 
chome c oxidase (complex IV) and H+-ATPase 
(complex V)-rotenone, azide and oligomycin, respec- 
tively. Due to the limited amount of tissue and to 
avoid possible artifacts of the preparation, we used 
saponin-skinned muscle fibers which allowed us to 
investigate mitochondrial function in situ, without 
isolation of mitochondria [4]. 
2. Methods 
2.1. Patients 
M.T. is a 34-year-old woman with ptosis and 
myopathy. K.G. is a 32-year-old woman with ptosis 
and severe myopathy. T.W. is a 31-year-old man 
with mild myopathy and severe ptosis. The three 
patients fulfill the clinical criteria of chronic progres- 
sive external ophthalmoplegia. In the muscle biopsy 
of M.T., K.G. and T.W. fibers with a very strong and 
spot-like stain for succinate dehydrogenase were 
found. In the three cases, deletions of the mitochon- 
drial DNA in skeletal muscle were detected. M.T. 
harbored in 53% of muscle mtDNA a 2.3 kb deletion 
located between the Hin dIII site at np 11680 and the 
XhoI site at np 14956. K.G. harbored in 84% of 
muscle mtDNA a 4.6 kb deletion including the 
Hin dIII site at np 11 680 and the Bam HI site at np 
14258. T.W. harbored in 65% of the muscle DNA the 
so-called 'common deletion' (5.0 kb, between np 
8468 and np 13446). N.N. was at the biopsy a 
32-ruth-old floppy female infant with a severe en- 
cephalomyopathy and epileptic strokes and died at 
the age of 35 month. In the muscle biopsy 'ragged 
red fibers' were detected. The presence of deletions 
and the 3243 MELAS point mutation was excluded. 
The densitometric analysis of the southern blots hy- 
bridized with probes for mtDNA and the nuclear 18S 
rDNA (cf. next part) revealed a decreased 
mtDNA/nuclear DNA ratio (24% of orthopedic on- 
trols) being indicative for the mtDNA depletion syn- 
drome [13]. D.S. is a 15-year-old boy with exercise 
intolerance and mild myopathy. The presence of dele- 
tions and the 3243 MELAS point mutation in the 
muscle biopsy was excluded. Elevated blood lactate 
levels (above 4 raM) - -  indicative for a diminished 
lactate utilization - -  were detected in all cases either 
at rest or during the recovery phase after defined 
bicycle ergometry (75 W). 
2.2. Southern blots 
1 /xg of Pvu II digested total DNA from muscle 
biopsy samples was separated on 0.7% agarose gels. 
Southern blots were hybridized with probes recogniz- 
ing linearized mtDNA as a 16.6 kb band and the 
human 18S-rRNA gene as a 12 kb band. Human 
mtDNA and a cloned fragment of the 18S-rRNA 
gene were digoxigenin labeled in two separate 
Klenow-reactions and mixed in a ratio revealing for 
control samples comparable intensities of both bands 
in densitometrical scans of X-ray films following 
CSPD-chemiluminescence. Dilution series revealed 
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that the signal-ratio was constant for DNA amounts 
of 0.2-2 /xg per lane. 
2.3. Isolation of saponin-skinned muscle fibers 
Bundles of fibers from musculus vastus lateralis 
were obtained from biopsy samples of myopathy 
patients and orthopedic patients (controls), dissected 
and treated with saponin essentially as described in 
[4]. 
lated by nonlinear egression analysis of the rotenone 
and oligomycin titration curves, accounting for the 
dissociation equilibrium of these inhibitors as de- 
scribed in [15-17] using the BMDP statistical soft- 
ware package. The flux control coefficient of the 
cytochrome c oxidase was determined from the ini- 
tial slopes of the titration curves of respiration with 
azide estimated by linear regression of the first titra- 
tion points, using as Kd-Value for azide, 64 /xM 
[12,18]. 
2.4. Respiration measurements 2.7. Statistical analysis 
The respiration measurements were performed at 
25°C using a high resolution Oroboros-oxygraph (An- 
ton Paar, Graz) in a medium consisting of 110 mM 
mannitol, 60 mM KC1, 10 mM KH2PO 4, 5 mM 
MgC12, 0.5 mM Na2EDTA, 10 mM glutamate, 5
mM malate and 60 mM Tris-HC1 (pH = 7.4). 
2.5. Enzyme activities in the homogenate of skeletal 
muscle 
The measurements were performed at 30°C using a 
Cary 1 spectrophotometer by standard methods in the 
medium for oxygraphic measurements [5,14]. 
2.6. Determination of flux control coefficients 
The flux control coefficients of the NADH:CoQ 
oxidoreductase and of the H+-ATPase were calcu- 
The results are presented as mean + S.D. Signifi- 
cant changes were assessed by Student's t-test. A 
value of P < 0.05 was accepted as the level of 
significance. 
3. Results 
In Table 1 the enzyme patterns of musculus vastus 
lateralis homogenates from three patients with chronic 
progressive xternal ophthalmoplegia (CPEO), one 
patient with mitochondrial DNA depletion syndrome 
(mtDNA D), one patient with a mitochondrial myopa- 
thy (MM) and from orthopedic patients (controls) are 
shown. In comparison to the orthopedic ontrols we 
observed elevated citrate synthase activities, pointing 
to an adaptational increase of mitochondria content 
[1,20]. Taking this into account, in the skeletal mus- 
Table 2 
Maximal mitochondrial respiratory activities of saponin-skinned muscle fibers 
nmol 02 /min /mg dry weight 
succ + rot oc + mal pyr + mal glu + real 
Controls 9.2 + 1.9 (N  = 18) 6.3 + 1.1 (N = 10) 8.1 -+ 2.0 (N = 10) 8.6 + 1.9 (N = 18) 
M.T. (CPEO) 8.3 + 2.1 (n = 4) 4.6 ± 0.8 (n = 2) 6.8 (n = 1) 6.2 + 0.8 (n = 3) 
NS NS NS NS 
K.G. (CPEO) 5.6 + 1 (n = 8) 3.9 _ 0.5 (n = 7) 3.0 _ 0.4 (n = 7) 3.4 + 0.6 (n = 14) 
P < 0.001 P < 0.001 P < 0.001 P < 0.001 
T.W. (CPEO) 9.3 + 1.1 (n = 6) 5.2 + 0.2 (n = 2) 7.0 _ 0.2 (n = 2) 7.9 _+ 1.7 (n = 10) 
NS NS NS NS 
N.N. (mtDNA D) 6.3 + 0.9 (n = 6) 4.9 + 0.4 (n = 4) 5.4 _ 0.5 (n = 5) 5.2 + 0.5 (n = 10) 
P < 0.01 NS P < 0.05 P < 0.001 
D.S. (MM) 9.8 + 0.9 (n = 4)NS 4.4 + 1.1 (n = 5)NS 8.1 _ 0.7 (n = 4)NS 8.6 + 1.2 (n = 10)NS 
The rates of respiration were determined using the substrates 10 mM succinate + 10/xM rotenone (succ + rot), 1 mM octanoylcamitine + 5 
mM malate (oc + mal), 10 mM pyruvate + 5 mM malate (pyr + real) or 10 mM glutamate + 5 mM malate (glu + mad in the presence of 
1 mM ADP as described in Section 2. N, number of orthopedic patients, n, number of independent determinations; NS, not significant. 
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cle homogenates of patients K.G., D.S. and T.W. 
decreased normalized (per citrate synthase) NADH: 
cytochrome c reductase activities were observed, 
K.G. had additionally decreased normalized cy- 
tochrome c oxidase and succinate:cytochrome c re- 
ductase activities and N.N. had a decreased normal- 
ized cytochrome c oxidase activity. In contrast o the 
clearly detectable abnormalities on the level of the 
mitochondrial genome in the skeletal muscle ho- 
mogenates of the patient M.T. no statistical signifi- 
cant enzymatic deficiency was found. 
A 5 rain 
succ ~ IDE (8 additions) 
B 5 min 
t I E"NT 
s ]cc  I '°E c8 - 
Fig. 1. Representative oxygraph traces of azide titrations of 
ADP-stimulated respiration of saponin-skinned muscle fibers. A: 
1.4 mg dry weight of skinned fibers from an orthopedic patient in 
1.5 ml of the medium for respiration measurements. Additions: 
ADP - -  1 mM, succinate (SUCC) - -  10 raM, azide additions 
(final concentrations in the chamber) - -  13.3 /xM, 33.3 /zM, 
66.7/xM, 100 /xM, 167 ~M, 300 /xM, 633 /xM, 1300 /xM. B: 
1.8 mg dry weight of skinned fibers from the patient M.T. in 1.5 
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Fig. 2. Azide titrations of the ADP-stimulated respiration of 
saponin-skinned muscle fibers. Experimental conditions like in 
Fig. 1. The maximal rates of oxygen consumption (in the pres- 
ence of 10 mM succinate and 1 mM ADP) are plotted versus the 
azide concentrations. A. Open circles - -  control fibers, L.4 mg 
dry weight; filled squares - -  patient M.T., 1.8 mg dry weight; 
filled circles - -  patient K.G., 1.9 mg dry weight. B. Open 
triangles - -  patient T.W., 1.7 mg dry weight; open squares - -  
patient D.S., 1.7 mg dry weight; filled triangles - -  patient N.N., 
1.8 mg dry weight. 
In order to elucidate possible reasons for this 
discrepancy we measured the maximal rates of mito- 
chondrial oxygen consumption using saponin-skinned 
muscle fibers from the same biopsies. These rates of 
ADP-stimulated mitochondrial respiration from the 
patients and the orthopedic ontrols are presented in 
Table 2. It can be seen that for the patients K.G. and 
N.N. the oxidation rates of the fibers with almost all 
substrates were lower, while for the patients M.T., 
T.W. and D.S. no significant differences to the con- 
trois were found. 
In order to quantify the possible metabolic effects 
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of putative enzymatic deficiencies in these diseases, 
we titrated the maximal rates of respiration with 
specific inhibitors of mitochondrial oxidative phos- 
phorylation. Typical titrations of the ADP-stimulated 
respiration of saponin-skinned muscle fibers with the 
noncompetitive inhibitor of cytochrome c oxidase 
azide are shown in the Fig. 1A and B. In Fig. 1A, the 
titration experiment was performed with skinned 
fibers of an orthopedic patient, and in Fig. 1 B with 
fibers of patient M.T. From the first derivative of the 
oxygen content (lower curves), which is the direct 
measure of the actual rate of respiration, it can be 
seen that initially identical additions of azide caused, 
in the case of the patient suffering from chronic 
progressive xternal ophthalmoplegia,  much more 
pronounced inhibition of respiratory flux. The de- 
tailed plots of velocities of respiration versus in- 
hibitor concentrations for all patients are shown in 
Fig. 2 A and B. A typical titration curve of skinned 
fibers from an orthopedic ontrol is shown in Fig. 2 
A (open circles). Only for the skinned fibers from 
patient M.T. (filled squares) an increased sensitivity 
of mitochondrial respiration to azide was detected. 
This is visible from the elevated initial slope of the 
titration curve. 
As already mentioned, metabolic control analysis 
offers the possibility of a quantitative valuation of 
flux control caused by an individual enzyme embed- 
ded within a metabolic pathway [7,8] and has been 
suggested to be useful for the description of enzy- 
matic abnormalities in syndromes related to mito- 
chondrial dysfunction [9,10]. For the quantitative de- 
scription this theory introduced the flux control coef- 
ficient C i, which gives a quantitative measure of the 
change in flux through a pathway caused by a small 
change in the concentration of an enzyme. If the 
controlling influence of an enzymatic reaction on the 
flux is large the value of the flux control coefficient 
is high approaching a maximal value of one (for 
simple unbranched pathways) [7,8]. Therefore, this 
parameter seems to be extremely useful for the quan- 
tification of changes in metabolism caused by enzy- 
matic defects. Using specific noncompetitive in- 
hibitors, the flux control coefficient can be deter- 
mined experimentally [15-17] according to the fol- 
lowing equation: 
C i = (d In J /dp i ) / (d  lnc JdP i  ) (1) 
where J is the flux through the pathway, v i is the 
activity of enzyme i and p~ is a specific inhibitor of 
enzyme i. From this the following equations can been 
derived: 
C~ = - (d J / J )  / (d pi/lmax ) (irreversible inhibitor) 
(2) 
C i = - (d J / J ) / (dP i /Kd)  (reversible inhibitor) 
(3) 
Table 3 
Flux control coefficients of mitochondrial enzymes in saponin-skinned muscle fibers of orthopedic patients and patients with chronic 
progressive external ophthalmoplegia 
Flux control coefficients 
NADH:CoQ oXidoreductase cytochrome c oxidase* H+-ATPase 
Controls 0.16 _+ 0.05 (N= 11) 0.21 _+ 0.05 (N= 14) 0.13 _+ 0.05 (N= 9) 
M.T. (CPEO) n.d. 0.44 _+ 0.06 (n = 2) n.d. 
P < 0.001 
K.G. (CPEO) 0.46 ___ 0.01 (n = 2) 0.24 _+ 0.06 (n = 6) 0.21 + 0.10 (n = 2) 
P < 0.001 NS NS 
T.W. (CPEO) 0.52 + 0.18 (n = 2) 0.23 _+ 0.01 (n = 6) n.d. 
P < 0.001 NS 
N.N. (rot DNA D) 0.09 _+ 0.01 (n = 2) 0.18 _+ 0.01 (n = 4) 0.14 + 0.17 (n = 2) 
NS NS NS 
D.S. (MM) 0.54 _+ 0.02 (n = 2)P < 0.001 0.17 _+ 0.06 (n = 7)NS 0.06 _+ 0.04 (n = 4)NS 
The values were determined from titration experiments with rotenone, azide and oligomycin, respectively, at maximal rates of respiration 
using the substrates l0 mM glutamate + 5 mM malate or * additionally 0 mM succinate inthe presence of 1 mM ADP as described in
Section 2. N, number of orthopedic patients; n, number of independent determinations; NS, not significant. 
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Applying this theory to the azide titrations of 
respiration of saponin-skinned fibers from patient 
M.T. shown in Fig. 2A, the calculation of the flux 
control coefficient of cytochrome c oxidase accord- 
ing to Eq. (3) yielded a value of 0.44_ 0.06 (two 
titrations), while an average value of 0.21 + 0.05 was 
determined for the control fibers of 14 orthopedic 
patients. For all other mitochondrial myopathy pa- 
tients similar low flux control coefficients of cy- 
tochrome c oxidase were found (cf. Table 3). 
In the next series of experiments we titrated the 
maximal glutamate oxidation rate of saponin-skinned 
fibers with rotenone - -  a specific inhibitor of 
NADH:CoQ oxidoreductase. In Fig. 3A and B repre- 
sentative titration curves of control fibers (Fig. 3A, 
open circles) and of fibers from the mitochondrial 
myopathy patients are shown. For this irreversible 
inhibitor we observed a strong sigmoidal titration 
curve for control fibers. This is typical for inhibitors 
with nearly irreversible binding properties acting on 
enzymes with low flux control coefficients. Using a 
curve fitting program, allowing to perform a nonlin- 
ear regression analysis of the titration curves accord- 
ing to Eq. (2) and taking into account he binding 
equilibrium of the inhibitor [15], the flux control 
coefficient of NADH:CoQ oxidoreductase was deter- 
mined to be in the range of 0.16 _ 0.05 for controls. 
The rotenone titration curves of respiration of fibers 
from the mitochondrial myopathy patients D.S. (open 
squares), K.G. (filled circles) and T.W. (open trian- 
gles) are different o the controls. For these cases we 
observed a nearly complete disappearance of the 
sigmoidal behavior indicating a substantial increase 
in flux control. The application of the curve fitting 
procedure to these titrations yielded flux control coef- 
ficients of 0.54 + 0.02 for D.S, 0.46 + 0.01 for K.G. 
and 0.52_ 0.18 for T.W. Moreover, the amount of 
rotenone needed for the complete inhibition of respi- 
ration with approximately the same amount of skinned 
fibers was lower for the patients compared to the 
controls. Taking into account hat the fibers of the 
patients contain more mitochondria per mg dry 
weight, this finding is an strong indication for a 
decreased number of rotenone binding sites per mito- 
chondrial protein. 
To determine the flux control coefficients of H +- 
ATPase we titrated the respiration rate of saponin- 
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Fig. 3. Rotenone titrations of the ADP-stimulated respiration of 
saponin-skinned muscle fibers. A: Open circles - -  orthopedic 
patient, 1.7 mg dry weight; open squares - -  patient D.S., 2.0 mg 
dry weight; filled circles - -  patient K.G., 2.2 mg dry weight of 
skinned fibers in the medium for respiration measurements con- 
taining 1 mM ADP. B: Open triangles - -  patient T.W., 2.5 mg 
dry weight; filled triangles - -  patient N.N., 1.6 mg dry weight of 
skinned fibers in the medium for respiration measurements con- 
taining 1 mM ADP. 
Typical titration curves of control fibers (open cir- 
cles) and of fibers from patients are shown in Fig. 4. 
Similar to the rotenone titrations we observed sig- 
moidal titration curves which yielded after the appli- 
cation of the regression analysis flux control coeffi- 
cients ranging from 0.1 to 0.2. In the case of fibers 
from the patient with the mtDNA depletion syndrome 
(filled triangles) we observed additionally a smaller 
sensitivity to oligomycin indicating less coupled mi- 
tochondria. 
In Table 3 the results of determinations of flux 
control coefficients of three complexes of oxidative 
phosphorylation for all five patients are summarized. 
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Fig. 4. Oligomycin titrations of the ADP-stimulated respiration of 
saponin-skinned muscle fibers. Open circles - -  orthopedic pa- 
tient, 1.9 mg dry weight; open squares - -  patient D.S., 1.7 mg 
dry weight; filled circles - -  patient K.G., 1.7 mg dry weight; 
filled triangles - -  patient N.N., 2.0 mg dry weight of skinned 
fibers in the medium for respiration measurements containing 1
mM ADP. 
For the patients harboring deletions of the mtDNA in 
skeletal muscle and the mitochondrial myopathy pa- 
tient D.S. elevated flux control coefficients of certain 
respiratory chain complexes were observed. How- 
ever, it is remarkable that for the patient with the 
mtDNA depletion syndrome (N.N.) no change in the 
distribution pattern of flux control coefficients was 
detected. 
4. Discussion 
In the present study, we used saponin-skinned 
fibers for the investigation of mitochondrial function 
in muscle biopsy samples of patients with mitochon- 
drial myopathies. This technique has been found to 
be very successful for the functional analysis of 
oxidative phosphorylation i  small human biopsy 
specimens due to the obviation of mitochondrial iso- 
lation and minimization of the amount of tissue 
needed for this assessment [4]. Applying titrations 
with the specific inhibitors of cytochrome c oxidase 
(azide), of NADH:CoQ oxidoreductase (rotenone) and 
of H+-ATPase (oligomycin), we observed changes in 
the action of inhibitors of mitochondrial oxidative 
phosphorylation i saponin-skinned skeletal muscle 
fibers of certain patients with mitochondrial my- 
opathies. These changes point to an increased sensi- 
tivity of the mitochondrial respiratory chain to the 
applied inhibitors and could be interpreted as a con- 
sequence of a decrease in inhibitor binding sites due 
to lower levels of the affected enzymes. This finding 
is in line with recent reports showing diminished 
levels of assembled oxidative phosphorylation com- 
plexes in mitochondrial encephalomyopathies with 
impaired mitochondrial protein biosynthesis [6,19] 
leading to a partial inhibition of respiratory chain 
[20]. 
In case of patients harboring deletions of the 
mtDNA in skeletal muscle, the metabolic effect of 
the individual mutation is difficult to predict [6]. As 
shown in the present work, the simple determination 
of activities of the individual respiratory chain com- 
plexes and of the maximal rates of mitochondrial 
respiration revealed for the patients M.T. and T.W. 
almost no statistical significant differences as com- 
pared to the controls (Table 1). However, the flux 
control coefficient of cytochrome c oxidase for pa- 
tient M.T. was found to be higher by the factor of 
two then in controls. On the other hand, for patient 
T.W. the flux control coefficient of NADH:CoQ 
oxidoreductase was considerably increased (Table 3). 
Thus, our data suggest hat the redistribution of the 
control of mitochondrial oxidative phosphorylation 
might be an important mechanism relating the geno- 
type (mtDNA deletion) to the diseased energy con- 
version processes, leading to the increased lactate 
levels observed for these patients (see Section 2). 
This flux control redistribution, which is caused in 
the described cases most probably by small non-pro- 
portional changes in enzyme activities (cf. citrate 
synthase normalized activities in Table 1), could 
therefore be one of the determinants of the global 
energy metabolism defect in the affected tissue, 
Moreover, due to the fact that the flux control 
coefficients of all - -  at least partially mtDNA en- 
coded - -  complexes of the mitochondrial inner mem- 
brane are rather low in skeletal muscle [17], metabolic 
control analysis offers a plausible explanation for the 
observed threshold effects in mitochondrial diseases 
[10,21]. As we demonstrated for the patients with 
rather mild forms of mitochondrial myopathies (M.T., 
T.W., D.S.), slightly changed activities of enzymes of 
the respiratory chain should not necessarily affect the 
maximal mitochondrial oxidative activity of 
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saponin-skinned muscle fibers, similar as we reported 
previously for skinned muscle fibers of copper-defi- 
cient Mo br mice [12]. In these cases only a redistribu- 
tion of flux control was observed. Alternately, in 
saponin-skinned muscle fibers of the patient with a 
severe form of CPEO - K.G., with 84% deleted 
mtDNA in muscle, in addition to the redistribution of
flux control, a lower maximal mitochondrial oxida- 
tion activity and a large decrease of all specific 
respiratory chain-linked activities (if expressed per 
citrate synthase) was detected. The application of 
metabolic ontrol analysis revealed for this patient 
the NADH:CoQ oxidoreductase as the enzyme being 
the mostly responsible for the decreased mitochon- 
drial energy conversion capacity. Interestingly, in the 
case of N.N. (mitochondrial DNA depletion syn- 
drome), where all mitochondrial encoded proteins are 
simultaneously affected, the maximal oxidation rates 
of fibers were decreased but no redistribution of flux 
control was observed (cf. Tables 2 and 3). 
Summarizing, the application of titrations with 
specific inhibitors within the framework of metabolic 
control analysis can be a helpful approach in analyz- 
ing the metabolic onsequences of complex defects 
of mitochondrial oxidative phosphorylation. More- 
over, due to the broad spectrum of available specific 
inhibitors of mitochondrial oxidative metabolism and 
due to the high sensitivity to small non-proportional 
changes in enzyme activities, it is suggested that this 
method is especially applicable for the elucidation 
and localization of enzymatic defects which are diffi- 
cult to visualize by conventional activity measure- 
meats. 
Acknowledgements 
The excellent technical assistance of Mrs. K. Kaiser 
and I. Schellhase is gratefully acknowledged. We are 
much obligated to Dr. Carol Macmillan (Montreal 
Neurological Institute and Hospital, Canada) who 
provided the cloned fragment of the human 18S 
rRNA gene. This work was supported by grants of 
the Land Sachsen-Anhalt (1795A/0084 and 
1919A/0025) and of the Deutsche Gesellschaft zur 
Bek~rnpfung yon Muskelkrankheiten. 
References 
[1] Wallace, D.C. (1992) Annu. Rev. Biochem. 61, 1175-1212. 
[2] Morgan-Hughes, J.A. (1994) Curr. Opin. Neurol. 7, 457- 
462. 
[3] Robinson, B.H. (1993) Biochim. Biophys. Acta 1182, 231- 
244. 
[4] Kunz, W.S., Kuznetsov, A.V., Schulze, W., Eichhorn, K., 
Schild, L., Striggow, F., Bohnensack, R., Neuhof, S., 
Grasshoff, H., Neumann, H.W. and Gellerich, F.N. (1993) 
Biochim. Biophys. Acta 1144, 46-53. 
[5] Kunz, D., Luley, C., Kunz, W.S., Winkler, K., Fritz, S., 
Bohnensack, R. and Wallesch, C.-W. (1995) Biochem. Mol. 
Med. 54, 105-111. 
[6] Bentlage, H., de Coo, R., ter Laak, H., Sengers, R., Trijbels, 
F., Ruitenbeek, W., Schlote, W., Pfeiffer, K., Gencic, S., 
yon Jagow, G. and Sch~igger, H. (1995) Eur. J. Biochem. 
227, 909-915. 
[7] Kacser, H. and Burns, J.A. (1973) In Rate Control of 
Biological Processes (Davies, D.D. ed.), Cambridge Univer- 
sity Press, London, pp. 65-104. 
[8] Heinrich, R. and Rapoport, T.A. (1974) Eur. J. Biochem. 
42, 97-105. 
[9] Taylor, R.W., Birch-Machin, M.A., Bartlett, K., Lowerson, 
S.A. and Turnbull, D.M. (1994) J. Biol Chem. 269, 3523- 
3528. 
[10] Letellier, T., Malgat, M. and Mazat, J.P. (1993) Biochim. 
Biophys. Acta 1141, 58-64. 
[11] Schuster, R. and Holzhiitter, H.-G. (1995) Eur. J. Biochem. 
229, 403-418. 
[12] Kuznetsov, A.V., Clark, J.F., Winkler, K. and Kunz, W.S. 
(1996) J. Biol. Chem. 271,283-288. 
[13] Moraes, C.T., Shanskke, S., Tritschler, H.-J., Aprille, J.R., 
Andreetta, F., Bonilla, E., Schon, E.A., DiMauro, S. (1991) 
Am. J. Hum. Gen. 48, 492-501. 
[ 14] Bergmeier, H.U. (1970) Methoden der enzymatischen A al- 
yse. 2. Auflage, Akademie Verlag, Berlin, 1970. 
[15] Gellerich, F.N., Kunz, W.S, and Bohnensack, R. (199t) 
FEBS Lett. 274, 167-170. 
[16] Wisniewski, E., Kunz, W.S. and Gellerich, F.N. (1993) J. 
Biol. Chem. 268, 9343-9346. 
[17] Wisniewski, E., Gellerich, F.N. and Kunz, W.S. (1995) Eur. 
J. Biochem. 230, 549-554. 
[18] Li, W. and Palmer, G. (1993) Biochemistry 32, 1833-1843. 
[19] Bentlage, H.A.C.M., Janssen, A.J.M., Chomyn, A., Attardi, 
G., Walker, J.E., Sch~igger, H., Sengers, R.C.A. and Trij- 
bels, F.J.M. (1995) Biochim. Biophys. Acta 1234, 63-73. 
[20] Winkler, K., Kuznetsov, A.V., Lins, H., Kirches, E., von 
Bossanyi, P., Dietzmann, K., Frank, B., Feistner, H. and 
Kunz, W.S. (1995) Biochim. Biophys. Acta 1272, 181-184. 
[21] Letellier, T., Heinrich, R., Malgat, M. and Mazat, J.-P. 
(1994) Biochem. J. 302, 171-174. 
